NEURAPRO-E: A Multicentre Randomized Controlled Trial of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Patients at Ultra High Risk of Schizophrenia and Other Psychotic Disorders
Version 2 2024-06-05, 11:38Version 2 2024-06-05, 11:38
Version 1 2016-10-01, 00:00Version 1 2016-10-01, 00:00
conference contribution
posted on 2024-06-05, 11:38authored byPatrick D McGorry, B Nelson, C Markulev, Alison YungAlison Yung, G Berger, L de Haan, A Riecher-Rossler, M Nordentoft, EY Chen, S Verma, Ian Hickie, GP Amminger
NEURAPRO-E: A Multicentre Randomized Controlled Trial of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Patients at Ultra High Risk of Schizophrenia and Other Psychotic Disorders